Methylprednisolone, IV Immunoglobulin, Tocilizumab, or Anakinra for Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS/MIS-C): Report From a Randomized, Controlled, Open-Label Platform Trial (Lancet Child and Adolescent Health)
Back to course
Video Transcription
Video Summary
Asset Caption
One-Hour Concurrent Session | Late-Breaking Studies Affecting Patient Outcomes II
Meta Tag
Content Type Presentation
Membership Level Professional
Membership Level Select
Year 2024
Keywords
PIMS-TS
pediatric trial
intravenous immunoglobulin
methylprednisolone
tocilizumab

   

   
 
Society of Critical Care Medicine

500 Midway Drive
Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847 439-7226
Email: support@sccm.org


Contact Us

About SCCM

Newsroom

Advertising & Sponsorship

DONATE


MySCCM

LearnICU

Patients & Families

Surviving Sepsis Campaign

Critical Care Societies Collaborative


kisspng-facebook-social-media-computer-icons-linkedin-soci-gray-5ac493cf1c2975.7867418415228323351154  - KW Symphony    Gray twitter 3 icon - Free gray social icons    Gray linkedin 3 icon - Free gray site logo icons    Gray instagram icon - Free gray social icons    YouTube Icon Gray Box - HONOR VETERANS NOW

GET OUR NEWSLETTER






© Society of Critical Care Medicine. All rights reserved.   |    Privacy Statement    |    Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.



Android App Download IOS App Download Powered By